ABSTRACT
INTRODUCTION

46
The vast majority of eukaryotic introns are spliced by the U2 spliceosome (the only alternative U12 47 spliceosome is responsible for <0.5% of all introns [1] [2] [3] ), which interacts with RNA sequences 48 specifying the 5' and 3' splice sites [4, 5] . In vertebrates, the 9-bp consensus sequence for the U2-type 49 5' splice site (5'SS) has traditionally been described as 5'-MAG/GURAGU-3' (where M denotes C or A,
50
R denotes A or G and / denotes the exon-intron boundary; the corresponding nucleotide positions are 51 denoted -3_-1/+1_+6) although in reality this consensus sequence does not reflect the true extent of 52 sequence variability [6] [7] [8] [9] [10] [11] . Base-pairing of this 9-bp sequence with 3'-GUCCAUUCA-5' at the 5' end of 53 U1 snRNA ( Figure 1A ) is critical for splicing to occur [10, [12] [13] [14] [15] . Although the GT dinucleotide in the 54 first two intronic positions (in the context of DNA sequence) is the most highly conserved portion of the 55 U2-type 5'SS, it was reported, as early as 1983, that GC occasionally occurs in place of GT [16] [17] [18] .
56
Subsequent genome-wide analyses have established that this non-canonical 5'SS GC is present as 57 wild-type in ~1% of human U2-type introns [2, 7, 8, 19, 20] . Importantly, the remaining nucleotides in 58 these evolutionarily fixed non-canonical GC 5'SSs exhibit a stronger complementarity to the 3'-
59
GUCCAUUCA-5' sequence at the 5' end of U1 snRNA than those in the canonical GT 5'SSs ( Figure   60 1A), thereby in all likelihood compensating for the decreased complementarity between the 5'SS and 61 the 5' end of U1 snRNA due to the U to C substitution [7, 8] . Comparative genome analyses have also 62 revealed frequent switching of U2-type introns from the canonical 5'SS GT subtype to the non-canonical 63 5'SS GC subtype during mammalian evolution [8, 21] . Finally, GC has recently been ranked first among 64 the six non-canonical 5′SSs identified by genome-wide RNA-seq analysis and splicing reporter assays 65 [22] .
66
The finding that GC occasionally occurs instead of GT within the canonical 5'SS in some vertebrate 67 genes implies that substitution of the canonical 5'SS GT by GC (termed a 5'SS GT>GC mutation) may 68 allow normal splicing to occur. The first direct experimental evidence supporting such a postulate came 69 in the late 1980s; analyses of both the splicing products of in vitro transcribed rabbit beta globin (Hbb) 
70
RNA in a HeLa cell nuclear extract and the splicing products of the Hbb gene transiently expressed in
71
HeLa cells demonstrated that, of all the possible single nucleotide substitutions of the canonical 5'SS
72
GT of the second and last intron of Hbb, only the substitution of T by C was compatible with normal 73 splicing, albeit at a much reduced rate (approximately 10% of normal; see also Figure 1B ) [23, 24] .
74
Further supporting evidence came from the study of disease-causing 5'SS GT>GC mutations, some of 75 which were reported to generate wild-type transcripts (see below). Additionally, the activation of cryptic 76 non-canonical 5'SS GC has also been reported as a consequence of some disease-causing mutations 77 [25, 26] .
78
The above notwithstanding, to date, the scale of canonical 5'SS GT>GC mutations generating wild-79 type transcripts, both in the context of the frequency of such mutations and the level of wild-type 80 transcripts generated by such mutations, remain unknown owing to the intrinsic complexity of splicing 81 [11, [27] [28] [29] Figure 1C ), we identified 45 disease-causing 5'SS GT>GC 94 mutations (from 42 genes) that were informative with respect to the presence or absence of wild-type 95 transcripts derived from the mutant allele (Table 1; see Supplementary Table S1 for more information   96 including affected intron, reference mRNA accession number, chromosomal location, hg38 coordinate,
97
and patient-derived tissue or cells used for RT-PCR analysis, etc.). It should be noted that the 98 assignments of "presence" or "absence" of mutant allele-derived wild-type transcripts depended upon 99 the agarose gel evaluation of RT-PCR products as described in the corresponding original publications.
100
Thus, we conservatively annotated an isolated case (i.e., the PCCB c.183+2T>C mutation), which was 
104
The 45 informative 5'SS GT>GC mutations comprised 30 homozygotes, 13 hemizygotes and 2 105 compound heterozygotes (Table 1) . Whilst the presence or absence of wild-type transcripts derived 106 from the mutant allele was straightforward for all homozygous or hemizygous mutations included, the 107 two compound heterozygotes required special treatment. In the case of the CD3E c.520+2T>C 108 mutation, the pathogenic CD3E mutation in trans was a nonsense mutation in exon 6. Sequencing of 109 the patient-derived, normal-sized RT-PCR products failed to demonstrate the exon 6 mutation,
110
suggesting that the wild-type transcripts were derived from the c.520+2T>C allele [34] . In the case of 111 the PNPLA2 c.757+2T>C mutation, the second PNPLA2 mutation in trans was a missense mutation, specificity of the splicing process in some instances [11, [27] [28] [29] . However, this may not always be 146 possible in practice, particularly if variants in multiple genes are to be analyzed in large-scale studies.
147
For example, a recent study that measured 5'SS activity in the context of three minigenes was 148 performed in transfected HeLa cells [11] . In the present study, we used HEK293T cells for transfection 149 as previously described [42, 46] .
150
Bearing in mind the aforementioned advantages and disadvantages, we employed a cell culture-151 based full-length gene splicing assay ( Figure 1C ). In brief, for various technical and practical reasons,
152
we firstly selected genes whose genomic sizes did not exceed 8 kb (from the translation initiation codon 
162
Only wild-type transcripts were observed for 10 of the aforementioned 19 5'SS GT>GC mutations
163
(e.g., FATE1 IVS1+2T>C in Figure 2B ). In other words, no aberrantly spliced transcripts were observed 164 in these 10 cases. It is possible that aberrantly spliced transcripts may be rendered invisible by RNA 165 degradation mechanisms such as nonsense-mediated mRNA decay (NMD) [47, 48] . One way to test 166 such a possibility is to add an NMD inhibitor such as cycloheximide [49] to the cell culture medium, 167 although this is beyond the scope of the present study. We quantified the relative level of correctly 168 spliced transcripts for these 10 5'SS GT>GC mutations by means of our previously described 169 quantitative 50, 51] . Here it is pertinent to mention that a co-transfected minigene 170 construct was used as an internal control in this analysis ( Figure 3A ), a prerequisite to obtain accurate 171 results. As shown in Figure 3B , the relative level of correctly spliced transcripts emanating from these 172 10 mutations is remarkably similar to that observed for the disease-causing 5'SS GT>GC mutations in 173 terms of the lowest extreme (2-5% vs. 1-5%); however, the functionally obtained highest level of 174 correctly spliced transcripts (84%) is much higher than the corresponding 15% value observed for the 175 disease-causing 5'SS GT>GC mutations (Table 1) . We were initially puzzled by this disparity, but this 176 could be accounted for by two considerations. On the one hand, the currently analyzed disease-causing 177 mutations were likely to be biased toward those that generated either no wild-type transcripts or only a 178 low level. On the other hand, given (i) that 5'SS GC may occur as wild-type in the human genome, (ii) 179 the highly degenerate nature of the 5'SS splice signal sequences and (iii) the complex regulation of the 180 splicing process in vivo, it is entirely possible that a 5'SS GT>GC mutation may behave similarly to its 181 original wild-type sequence. This notwithstanding, no single GC mutation was noted to have an identical 182 or higher normal splicing activity than its 5'SS GT counterpart ( Figure 3B ).
183
Additionally, the single RT-PCR band of wild-type transcript size from either the wild-type CCDC103 184 gene or the CCDC103 IVS1+2T>C mutant (refer to Supplementary Figure S1 ) was revealed by Sanger 185 sequencing to comprise the correctly spliced transcript and an alternatively spliced transcript; the level 186 of the correctly spliced transcripts generated from the mutant allele was estimated to be ~18% of that 187 generated from the wild-type allele based upon evaluation of the corresponding sequence peak heights
188
(Supplementary Figure S2) . By contrast, we did not attempt to quantify the relative expression level of 189 correctly spliced transcripts for the remaining 8 GT>GC mutations due to the co-presence of aberrantly 190 spliced transcripts (e.g., DBI IVS2+2T>C in Figure 2B ). Nonetheless, based upon the relative intensities 
194
Finally, we sequenced some aberrantly spliced transcripts (n=12), which resulted from exon 195 skipping, retention of intronic sequence or deletion of partial exonic sequences (Table 2) . Notably, the
196
PRSS2 IVS4+2T>C mutation activated a cryptic 5'SS GC that is located 15 bp upstream of the normal 197 one, resulting in the deletion of the last 17 bp of exon 4 (i.e., the major band generated by PRSS2 198 IVS4+2T>C; Figure 2B ). 
215
GUCCAUUCA-5' sequence at the 5' end of U1 snRNA ( Figure 1A) . We surmised that the canonical 216 5'SSs whose substitutions of GT by GC generated normal transcripts (termed group 1) should also 217 exhibit stronger complementarity to the aforementioned 9-bp sequence than those sites whose 218 substitutions of GT by GC did not lead to the generation of normal transcripts (termed group 2). We Table S1 ).
230
We also explored whether the creation or disruption of splice enhancer/silencer motifs by the 5'SS 231 GT>GC mutations could be associated with the generation or not of some wild-type transcripts. To this 232 end, we employed ESEfinder and RESUE-ESE provided by the Alamut suite under default conditions.
233
We were unable to draw any meaningful conclusions, primarily due to the short and degenerate nature 
240
GT>GC mutations that generated at least some wild-type transcript ( Figure S3) . Notably, one of the mutations affected the splice 261 donor splice site of HBB intron 2 (i.e., HBB c.315+2T>C) [55] , site of the previously analyzed 262 orthologous mutation in the rabbit Hbb gene [23, 24] . We were able to study the effect of the HBB intron 263 2 GT>GC mutation on splicing by means of the full-length gene assay and found that it had indeed 264 retained the ability to generate normal HBB transcripts ( Figure 5 ).
266
Prediction of the Functional Effect of 5'SS GT>GC Mutations
267
Finally, it is important to point out that none of the splicing prediction tools were able to accurately 268 predict the functional effect of 5'SS GT>GC mutations. For example, we analyzed the 45 disease-269 causing 5'SS GT>GC mutations as well as the 19 functionally analyzed 5'SS GT>GC mutations that 270 generated some wild-type transcripts by means of the widely used Alamut ® software suite under default 271 conditions. Whereas SpliceSiteFinder-like tended to predict a slightly reduced score, MaxEntScan,
272
NNSPLICE and GeneSplicer invariably gave no scores, for all mutations tested (Table 1; 273 Supplementary Table S3 ).
275
Conclusions
276
Based upon complementary data from the meta-analysis of 45 disease-causing 5'SS GT>GC mutations 
295
starting material. The procedure of the meta-analysis is described in Figure 1C .
297
Cell Culture-Based Full-Length Gene Splicing Assay
298
Outline of the cell culture-based full-length gene splicing assay is illustrated in Figure 1C . 
315
Cloning of the amplified full-length wild-type gene sequences into the expression vector
316
Early experiments were performed by means of TA cloning. In those cases in which the PCR products 317 contained multiple bands, the band of the expected size was gel purified using the QIAquick Gel
318
Extraction Kit (Qiagen) and 3'-A overhangs added; in cases where a single and expected band was 
325
Plasmid constructs containing inserts in the right orientation were selected by PCR screening using the 326 HotStarTaq Master Mix Kit (Qiagen).
327
Later experiments were performed by means of in-fusion cloning. PCR products of the expected 328 size were purified using the QIAquick Gel Extraction Kit (Qiagen) after gel electrophoresis. The purified 329 products were cloned into EcoRI restriction site of the linearized pcDNA3.1(+) vector with the In-Fusion 
332
Transformed cells were spread onto LB agar plates with 50 µg/mL ampicillin and incubated at 37°C 333 overnight. Plasmid constructs containing inserts were confirmed by PCR using the HotStarTaq Master
334
Mix Kit (Qiagen).
336
Mutagenesis
337
Variants were introduced into the wild-type full-length gene expression constructs by means of the
338
QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies). Mutagenesis was performed in 339 a 25.5 μL mixture containing 1.25 U PfuUltra HF DNA polymerase, 0.5 μL dNTP mix, 2.5 μL 10× 340 reaction buffer, 1.5 μL QuikSolution, 100 ng wild-type plasmid, and 62.5 ng each mutagenesis primer 341 (primer sequences available upon request). The PCR program had an initial denaturation at 95°C for 2 342 min, followed by 18 cycles of denaturation at 95°C for 1 min, annealing at 60°C for 50 s, and extension 343 at 68°C for 1 min/kb, and a final extension at 68°C for 7 min. The PCR products were transformed into 344 XL10-Gold Ultracompetent cells (Agilent Technologies) after treated with DpnI at 37°C for 1 h.
345
Transformed cells were spread onto LB agar plates with 50 µg/mL ampicillin and incubated at 37°C 
369
The PCR program had an initial denaturation step at 95°C for 15 min, followed by 30 cycles of 370 denaturation at 94°C for 45 s, annealing at 58°C for 45 s, and extension at 72°C for 1 min/kb (in the step 371 to screen wild-type genes for which RT-PCR analysis of transfected cells generated a single or quasi- 
381
The relative level of correctly spliced transcripts in association with GT>GC mutations that generated 382 only wild-type transcripts (confirmed by Sanger sequencing) was determined by real-time quantitative
383
RT-PCR analyses, essentially as described elsewhere [44, 46, 50] . Results were from three 384 independent transfection experiments, with each experiment being performed in three replicates. 
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